GoKawiilPericyte myosin inhibitor R(+)2501 restores capillary blood flow after kidney ischemia in animal study
Researchers found that renal capillary blood flow in animals becomes refractory to restoration by reperfusion alone once artery occlusion exceeds roughly 10-30 minutes, with pericytes remaining constricted even after large-vessel flow resumes. Administering an intravenous bolus of the compound R(+)2501 after occlusion periods of up to 120 minutes rapidly restored red blood cell velocity and flux to healthy levels within about 6 minutes, and in some cases pushed flow above baseline.
GoKawiil's interpretation of the reporting above, not reported fact.
The findings suggest capillary no-reflow, not just large-artery blockage, may be a key driver of lasting tissue damage after ischemic events like kidney injury, stroke or heart attack. If a pericyte-targeted drug can reopen stalled capillaries even after reperfusion has failed to do so, researchers may be pointing toward a new therapeutic strategy for conditions where restoring blood flow to large vessels hasn't been enough to prevent damage, though this evidence so far comes from animal experiments only.
- Kidney capillaries lose regenerative capacity after about 10-30 minutes of occlusion, becoming unresponsive to reperfusion alone.
- The compound R(+)2501 restored red blood cell velocity and flux to healthy ranges within 6 minutes across occlusion times up to 120 minutes.
- In healthy and treated capillaries, R(+)2501 could push blood flow above normal regulated levels, suggesting a pericyte-targeted mechanism beyond simple reflow.
Source: nature.com — Pénzes, 2026-10-14
Published there as: “Capillary-selective vasodilation through myosin inhibition halts ischaemic cascades”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.